Drug · DIN 02527693
ORLADEYO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 6, 2022; first marketed September 6, 2022.
- Drug Identification Number (DIN)
- 02527693
- Company (DIN owner)
- Biocryst Pharmaceuticals IncDurham, North Carolina, United States
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Berotralstat B06AC06
- Class
- Human
- Record last updated
- June 29, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BEROTRALSTAT (BEROTRALSTAT HYDROCHLORIDE) | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 2, 2022: NOC 28315New Drug Submission (NDS)